{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:45:56Z","timestamp":1791909956066,"version":"4.3.4"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.intimp.2015.04.037","type":"journal-article","created":{"date-parts":[[2015,4,28]],"date-time":"2015-04-28T01:16:59Z","timestamp":1430183819000},"page":"8-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Trastuzumab-based chemotherapy modulates systemic redox homeostasis in women with HER2-positive breast cancer"],"prefix":"10.1016","volume":"27","author":[{"given":"L.G.T.","family":"Lemos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.J.","family":"Victorino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.C.S.A.","family":"Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.F.","family":"Aranome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.L.","family":"Cecchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.N.C.","family":"Sim\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Panis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Cecchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2015.04.037_bb0005","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"Cancer J. Clin."},{"key":"10.1016\/j.intimp.2015.04.037_bb0010","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1042\/BJ20111451","article-title":"Autophagy, mitochondria and oxidative stress: cross-talk and redox signaling","volume":"441","author":"Lee","year":"2012","journal-title":"Biochem. J."},{"key":"10.1016\/j.intimp.2015.04.037_bb0015","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1038\/485S50a","article-title":"The hard facts","volume":"485","author":"Maxmen","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2015.04.037_bb0020","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.3798106","article-title":"Human breast cancer: correlation of relapse and survival with amplification of the HER-2\/neu oncogene","volume":"235","author":"Slamon","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.intimp.2015.04.037_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.3001539","article-title":"Improving treatment of HER2-positive cancers: opportunities and challenges","volume":"4","author":"Stern","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.intimp.2015.04.037_bb0030","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3816\/CBC.2008.n.047","article-title":"Unraveling the biologic and clinical complexities of HER2","volume":"8","author":"Park","year":"2008","journal-title":"Clin. Breast Cancer"},{"key":"10.1016\/j.intimp.2015.04.037_bb0035","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1093\/annonc\/12.suppl_1.S3","article-title":"The basic biology of HER2","volume":"12","author":"Rubin","year":"2001","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.intimp.2015.04.037_bb0040","first-page":"1","article-title":"Rhein induces apoptosis in human breast cancer cells","volume":"2011","author":"Chang","year":"2012","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"2","key":"10.1016\/j.intimp.2015.04.037_bb0045","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.bbrc.2004.11.028","article-title":"Vitamin E analogs trigger apoptosis in HER2\/erbB2-overexpressing breast cancer cells by signaling via the mitochondrial pathway","volume":"326","author":"Wang","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.intimp.2015.04.037_bb0050","doi-asserted-by":"crossref","first-page":"6102","DOI":"10.1038\/sj.onc.1203973","article-title":"Molecular mechanisms underlying ErbB2\/HER2 action in breast cancer","volume":"19","author":"Harari","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.intimp.2015.04.037_bb0055","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/ncb1485","article-title":"Par6\u2013aPKC uncouples ErbB2 induced disruption of polarized epithelial organization from proliferation control","volume":"8","author":"Aranda","year":"2006","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.intimp.2015.04.037_bb0060","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1128\/MCB.21.3.893-901.2001","article-title":"Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase","volume":"21","author":"Kim","year":"2001","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.intimp.2015.04.037_bb0065","first-page":"1823","article-title":"Induction of cancer cell migration by epidermal growth factor is initiated by specific phosphorylation of tyrosine 1248 of c-erbB-2 receptor via EGFR1","author":"Dittmar","year":"2002","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.intimp.2015.04.037_bb0070","first-page":"70","article-title":"Trastuzumab-induced cardiac dysfunction: a \u201cdual-hit\u201d","volume":"16","author":"Zeglinski","year":"2011","journal-title":"Exp. Clin. Cardiol."},{"key":"10.1016\/j.intimp.2015.04.037_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20061131","article-title":"Oxidative stress and cancer: have we moved forward?","volume":"401","author":"Halliwell","year":"2007","journal-title":"Biochem. J."},{"issue":"27","key":"10.1016\/j.intimp.2015.04.037_bb0080","doi-asserted-by":"crossref","first-page":"10137","DOI":"10.1073\/pnas.0403621101","article-title":"NF-kB activation in human breast cancer specimens and its role in cell proliferation and apoptosis","volume":"101","author":"Biswas","year":"2004","journal-title":"PNAS"},{"key":"10.1016\/j.intimp.2015.04.037_bb0085","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/978-1-4757-9480-9_9","article-title":"Identification of hydrogen peroxide as the relevant messenger in the activation pathway of transcription factor NF-kappa\u03b2","volume":"387","author":"Schmidt","year":"1996","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.intimp.2015.04.037_bb0090","first-page":"2825","article-title":"Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2\/neu overexpressing human breast cancer xenografts","volume":"58","author":"Baselga","year":"1998","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.intimp.2015.04.037_bb0095","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1074\/jbc.M804570200","article-title":"Blockade of the erbB2 receptor induces cardiomyocyte death through mitochondrial and reactive oxygen species-dependent pathways","volume":"284","author":"Gordon","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2015.04.037_bb0100","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1056\/NEJMra043186","article-title":"Trastuzumab-mechanism of action and use in clinical practice","volume":"357","author":"Hudis","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2015.04.037_bb0105","first-page":"1","article-title":"Trastuzumab and heart failure","volume":"8","author":"Tsang","year":"2007","journal-title":"Cardiol. Rounds"},{"issue":"2","key":"10.1016\/j.intimp.2015.04.037_bb0110","first-page":"737","article-title":"Screening of circulating TGF-\u03b2 level and its clinicopathological significance in human breast cancer","volume":"33","author":"Panis","year":"2013","journal-title":"Anticancer Res."},{"key":"10.1016\/j.intimp.2015.04.037_bb0115","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00262-011-1117-0","article-title":"Immunological effects of taxol and adryamicin in breast cancer patients","volume":"61","author":"Panis","year":"2012","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.intimp.2015.04.037_bb0120","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10549-011-1693-x","article-title":"Oxidative stress and hematological profiles of advanced breast cancer patients subjected to paclitaxel or doxorubicin chemotherapy","volume":"133","author":"Panis","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.intimp.2015.04.037_bb0125","author":"INCA"},{"issue":"21","key":"10.1016\/j.intimp.2015.04.037_bb0130","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1200\/JCO.2003.12.109","article-title":"Pharmacokinetics, safety and efficacy of trastuzumab administered every three weeks in combination with paclitaxel","volume":"21","author":"Leyland-Jones","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.intimp.2015.04.037_bb0135","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1007\/s00262-012-1283-8","article-title":"Molecular status is determinant on inflammatory status and immunological profile from invasive breast cancer patients","volume":"61","author":"Herrera","year":"2012","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.intimp.2015.04.037_bb0140","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s11357-012-9431-9","article-title":"Decreased oxidant profile and increased antioxidant capacity in naturally postmenopausal women","volume":"35","author":"Victorino","year":"2013","journal-title":"Age"},{"key":"10.1016\/j.intimp.2015.04.037_bb0145","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.exppara.2010.06.030","article-title":"Trypanosoma cruzi: effect of the absence of 5-lipoxygenase (5-LO)-derived leukotrienes on levels of cytokines, nitric oxide and iNOS expression in cardiac tissue in the acute phase of infection in mice","volume":"127","author":"Panis","year":"2011","journal-title":"Exp. Parasitol."},{"issue":"12","key":"10.1016\/j.intimp.2015.04.037_bb0150","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1177\/0961203311411350","article-title":"Oxidative stress is associated with liver damage, inflammatory status, and corticosteroid therapy in patients with systemic lupus erythematosus","volume":"20","author":"Lozovoy","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.intimp.2015.04.037_bb0155","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1002\/pmic.201200066","article-title":"Label-free MSE proteomic analysis of chronic myeloid leukemia bone marrow plasma: disclosing new insights from therapy resistance","volume":"12","author":"Pizzatti","year":"2012","journal-title":"Proteomics"},{"key":"10.1016\/j.intimp.2015.04.037_bb0160","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s10549-011-1851-1","article-title":"Differential oxidative status and immune characterization of the early and advanced stages of human breast cancer","volume":"133","author":"Panis","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"issue":"12","key":"10.1016\/j.intimp.2015.04.037_bb0165","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1158\/1055-9965.EPI-05-0015","article-title":"Role of lipid peroxidation in the epidemiology and preventions of breast cancer","volume":"14","author":"Gago-Dominguez","year":"2005","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"1","key":"10.1016\/j.intimp.2015.04.037_bb0170","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1586\/14789450.6.1.43","article-title":"Protein profile analysis of the breast microenvironment to differentiate healthy women from breast cancer patients","volume":"6","author":"Manello","year":"2009","journal-title":"Expert Rev. Proteomics"},{"issue":"1","key":"10.1016\/j.intimp.2015.04.037_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2006.10.029","article-title":"Dual role of hydrogen peroxide in cancer: possible relevance to cancer chemoprevention and therapy","volume":"252","author":"L\u00f3pez-L\u00e1zaro","year":"2007","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.intimp.2015.04.037_bb0180","first-page":"149","article-title":"Matrix metalloproteinase activity and glycosaminoglycans in chronic venous disease: the linkage among cell biology, pathology and translational research","volume":"3","author":"Manello","year":"2011","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.intimp.2015.04.037_bb0185","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1124\/pr.56.2.6","article-title":"Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity","volume":"56","author":"Minotti","year":"2004","journal-title":"Pharmacol. Rev."},{"issue":"4","key":"10.1016\/j.intimp.2015.04.037_bb0190","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/jnci\/djj049","article-title":"Improvement of the therapeutic index of anticancer drugs by the superoxide dismutase mimic mangafodipir","volume":"98","author":"Alexandre","year":"2006","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.intimp.2015.04.037_bb0195","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11523-009-0112-2","article-title":"Cardiac toxicity with anti-HER2 therapies\u2014what have we learned so far?","volume":"4","author":"Azambuja","year":"2009","journal-title":"Target. Oncol."},{"key":"10.1016\/j.intimp.2015.04.037_bb0200","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/sj.bjp.0705776","article-title":"Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and a what do the results mean?","volume":"142","author":"Halliwell","year":"2004","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.intimp.2015.04.037_bb0205","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1016\/S0021-9258(20)64313-7","article-title":"Peroxynitrite oxidation to sulfhydryls","volume":"266","author":"Radi","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"42","key":"10.1016\/j.intimp.2015.04.037_bb0210","doi-asserted-by":"crossref","first-page":"26066","DOI":"10.1016\/S0021-9258(18)47160-8","article-title":"Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation","volume":"269","author":"Rubbo","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2015.04.037_bb0215","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1177\/014107688908201216","article-title":"Tell me about free radicals, doctor: a review","volume":"82","author":"Halliwell","year":"1989","journal-title":"J. R. Soc. Med."},{"issue":"11","key":"10.1016\/j.intimp.2015.04.037_bb0220","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S0891-5849(00)00394-4","article-title":"Total antioxidant capacity as a tool assess redox status: critical view and experimental data","volume":"29","author":"Ghiselli","year":"2000","journal-title":"Free Radic. Biol. Med."},{"issue":"6","key":"10.1016\/j.intimp.2015.04.037_bb0225","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3109\/10409239509083491","article-title":"The glutathione S-transferase supergene family: regulation of GST and the contribution to the isoenzymes to cancer chemoprotection and drug resistance","volume":"30","author":"Hayes","year":"1995","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"issue":"5","key":"10.1016\/j.intimp.2015.04.037_bb0230","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nm0502-459","article-title":"ErbB2 is essential in the prevention of dilated cardiomyopathy","volume":"8","author":"Crone","year":"2002","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.intimp.2015.04.037_bb0235","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2004.08.066","article-title":"Inhibition of ErbB2 causes mitochondrial dysfunction in cardiomyocytes: Implications for herceptin-induced cardiomyopathy","volume":"44","author":"Grazzette","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.intimp.2015.04.037_bb0240","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/rheumatology\/keh317","article-title":"Protein oxidation status in patients with ankylosing spondylitis","volume":"43","author":"Yazici","year":"2004","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.intimp.2015.04.037_bb0245","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1007\/s13277-013-1391-x","article-title":"Overexpression of HER2\/neu protein attenuates the oxidative systemic profile in women diagnosed with breast cancer","volume":"35","author":"Victorino","year":"2014","journal-title":"Tumor Biol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576915002015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576915002015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:49:31Z","timestamp":1791906571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576915002015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S1567576915002015"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2015.04.037","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trastuzumab-based chemotherapy modulates systemic redox homeostasis in women with HER2-positive breast cancer","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2015.04.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}